As per ruling of the case, filed against the medicinal companies Teva Pharmaceutical Industries Ltd. and Baxter International Inc, both have to pay penalty of $90 million for selling used vials of anesthetic solution Propofol.

The issue came to notice after an outbreak of hepatitis C in Las Vegas four years back, where the bottles were found being reused at clinics of colonoscopy. Also, the doctor of the clinics is facing a trial on mistreating the patients.

The case was filed in the year 2008 by a retired US Air Force mechanic Michael Washington, who claimed that he was given anesthesia from an already used glass bottle, which is an unlawful act. He told the court that he contracted Hepatitis C when he went to a clinic to take colonoscopy test in July 2007.

Judges hearing the case, filed by Mr. Washington, found medicinal companies at fault and ordered Teva to pay penalty of $60 million and Baxter to pay fine of $30 million, out of which, the jury provided Mr. Washington a compensation of $14 million for the loss.

This case makes a total of three cases of penalty for violating medicinal laws against the two medicine manufacturing companies. The Israel based Teva Pharmaceutical Industries Ltd. had to pay $162 million for anesthesia Propofol provided by faulty means in the market.

Denise Bradley, a US-based Spokeswoman for Teva said, “We believe that the allegations against Teva are without merit and we plan to appeal this decision”.